These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35793009)

  • 1. MiR-135b improves proliferation and regulates chemotherapy resistance in ovarian cancer.
    Wang J; Zhang R; Zhang B; Zhang L; Jiang W; Liu X; Duan X
    J Mol Histol; 2022 Aug; 53(4):699-712. PubMed ID: 35793009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma.
    Zhong L; Liu X; Wang L; Liu Y; Zhang D; Zhao Y
    J Ovarian Res; 2022 Jan; 15(1):7. PubMed ID: 35027053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN.
    Duan XM; Liu XN; Li YX; Cao YQ; Silayiding A; Zhang RK; Wang JP
    Kaohsiung J Med Sci; 2019 Nov; 35(11):659-671. PubMed ID: 31332950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.
    Zhou S; Xu A; Song T; Gao F; Sun H; Kong X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):650-660. PubMed ID: 32186927
    [No Abstract]   [Full Text] [Related]  

  • 5. Mir-30b-3p affects the migration and invasion function of ovarian cancer cells by targeting the CTHRC1 gene.
    Li Y; Zhou J; Wang J; Chen X; Zhu Y; Chen Y
    Biol Res; 2020 Mar; 53(1):10. PubMed ID: 32156314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of microRNA-1271 on ovarian cancer via inhibition of epithelial-mesenchymal transition and cisplatin resistance.
    Chen Y; Wang L; Zhou J
    J Obstet Gynaecol Res; 2019 Nov; 45(11):2243-2254. PubMed ID: 31411791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B.
    Niu Q; Liu Z; Gao J; Wang Q
    Yonsei Med J; 2019 Dec; 60(12):1146-1156. PubMed ID: 31769245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-135a promotes proliferation, migration, invasion and induces chemoresistance of endometrial cancer cells.
    Wang J; Zhang L; Jiang W; Zhang R; Zhang B; Silayiding A; Duan X
    Eur J Obstet Gynecol Reprod Biol X; 2020 Jan; 5():100103. PubMed ID: 32021975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of MicroRNA-210 on the Growth of Ovarian Cancer Cells and the Efficacy of Radiotherapy.
    Zhao Y; Liu S; Wen Y; Zhong L
    Gynecol Obstet Invest; 2021; 86(1-2):71-80. PubMed ID: 33260174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 11. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
    Zhou J; Chen Q
    FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
    Ge T; Liu T; Guo L; Chen Z; Lou G
    Exp Cell Res; 2020 Nov; 396(1):112241. PubMed ID: 32835657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge.
    Li QH; Liu Y; Chen S; Zong ZH; Du YP; Sheng XJ; Zhao Y
    Biomed Pharmacother; 2019 Jun; 114():108832. PubMed ID: 30965236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2.
    Zhang Z; Che X; Yang N; Bai Z; Wu Y; Zhao L; Pei H
    Biomed Pharmacother; 2017 Dec; 96():1341-1348. PubMed ID: 29196101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
    Li X; Chen W; Jin Y; Xue R; Su J; Mu Z; Li J; Jiang S
    Biochem Pharmacol; 2019 Mar; 161():98-112. PubMed ID: 30639456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.
    Zhou B; Xu H; Xia M; Sun C; Li N; Guo E; Guo L; Shan W; Lu H; Wu Y; Li Y; Yang D; Weng D; Meng L; Hu J; Ma D; Chen G; Li K
    Front Med; 2017 Jun; 11(2):214-222. PubMed ID: 28470508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-513a-3p inhibits EMT mediated by HOXB7 and promotes sensitivity to cisplatin in ovarian cancer cells.
    Chen Y; Zhao XH; Zhang DD; Zhao Y
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10391-10402. PubMed ID: 33155195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
    Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
    Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-483-3p Promotes Proliferation, Migration, and Invasion and Induces Chemoresistance of Wilms' Tumor Cells.
    Che G; Gao H; Tian J; Hu Q; Xie H; Zhang Y
    Pediatr Dev Pathol; 2020; 23(2):144-151. PubMed ID: 31498707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.